Govt Rejects SII Plea To Export 50 Lakh Doses Of Covishield To UK

NEW DELHI : Despite the international pressure and several rounds of negotiations by Serum Institute of India (SII), the government has turned down the request from SII to export 50 lakh doses of Covishield to UK under its prior commitments.

The decision was taken in the wake of severe supply crunch of vaccines locally and government insisting the local production be supplied to protect Indians first.

States have been prompted to approach the Pune-based company to negotiate contracts to procure these doses to meet local demand. The doses are likely to be used to vaccinate those between 18-44 age.

“These 50 lakh doses of Covishield vaccine are now available for inoculating people between 18-44 years age. States have been asked to procure it. Private hospitals can also get them,” an official source said.

The ministry has asked the states to contact the company and initiate procurement activity at the earliest. However, sources said, the labels of these doses may have to be changed. Since the vaccines were packed for supply to the UK, a different label was affixed on the vials but now since they have to be supplied in the local market, they need a label for the same.

  • Related Posts

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    New Delhi: The entry of semaglutide generics in India is ‘stimulating’ market growth and providing a favourable push to Eli Lilly’s blockbuster brand Mounjaro (tirzepatide), said Patrik Jonsson, Executive Vice…

    Pak-made illegal cosmetics recovered from Itwari shop

    Nagpur: Maharashtra Food and Drug Administration (FDA), Nagpur Division, raided a cosmetics firm in Itwari market and seized Pakistan-origin beauty products suspected to have harmful mercury and steroids last week. The…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    Pak-made illegal cosmetics recovered from Itwari shop

    Pak-made illegal cosmetics recovered from Itwari shop

    Licences of 20 medical stores suspended after inspections

    Licences of 20 medical stores suspended after inspections

    Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

    Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

    Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

    Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

    HP accounts for 47 inferior drugs in March alert

    HP accounts for 47 inferior drugs in March alert